Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase Ib/II dose-escalation and dose-expansion study

作者：Li Zhou, Kun Yang, S. Zhang, Xieqiao Yan, Suming Li, Huayan Xu, Jingyuan Li, Yeqiang Liu, Bo Tang, Z.H. Chi, Lu Si, C-L. Cui, Hongqian Guo, Zhijiang He, Jianming Guo, Xinan Sheng · 发表于：Annals of Oncology · 年份：2024 · DOI：10.1016/j.annonc.2024.12.002 · 被引用次数：56 · 研究领域：Bladder and Urothelial Cancer Treatments、HER2/EGFR in Cancer Research、Esophageal Cancer Research and Treatment